Ostium Medicomm Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 01-07-2024
- Paid Up Capital ₹ 75.00 K
as on 01-07-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -3.04%
(FY 2022)
- Profit 235.06%
(FY 2022)
- Ebitda 145.49%
(FY 2022)
- Net Worth 31.84%
(FY 2022)
- Total Assets 20.32%
(FY 2022)
About Ostium Medicomm
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 75.00 K , as per Ministry of Corporate Affairs (MCA) records.
Ahobilam Nagasundaram, Markandeyulu Garimella, and Rajesh Enjamoori serve as directors at the Company.
- CIN/LLPIN
U74999KA2016PTC095434
- Company No.
095434
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2016
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ostium Medicomm?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ahobilam Nagasundaram  | Director | 08-May-2023 | Current |
| Markandeyulu Garimella | Director | 01-Aug-2016 | Current |
| Rajesh Enjamoori | Director | 01-Aug-2016 | Current |
Financial Performance of Ostium Medicomm.
Ostium Medicomm Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 3.04% decrease. The company also saw a substantial improvement in profitability, with a 235.06% increase in profit. The company's net worth Soared by an impressive increase of 31.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ostium Medicomm?
In 2019, Ostium Medicomm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Braincapitol Technologies Private LimitedActive 5 years 4 monthsAhobilam Nagasundaram is a mutual person
- Computefirst Technology Maintenance Services Private LimitedActive 3 years 5 months
Markandeyulu Garimella is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ostium Medicomm?
Ostium Medicomm has a workforce of 9 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ostium Medicomm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ostium Medicomm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
